Helping people with HIV reduce unhealthy drinking using CETA counseling
CETA-CORE
This project will offer a counseling program called CETA to help adults with HIV cut down on unhealthy drinking and stay on HIV treatment in Zambia and Alabama.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11173876 on NIH RePORTER |
What this research studies
As someone living with HIV, this program uses a counseling approach called the Common Elements Treatment Approach (CETA) plus a brief alcohol intervention delivered at HIV clinics to help reduce unhealthy drinking. Two linked clinical trials in Zambia and Alabama will compare how well these clinic-based treatments work, examine who benefits most and why, and train local providers to deliver the interventions with ongoing supervision. The team will also study costs and real-world implementation issues to support wider use if the approach works.
Who could benefit from this research
Good fit: Adults (21+) living with HIV who report unhealthy alcohol use and receive care at participating HIV clinics in Zambia or Alabama.
Not a fit: People who do not drink at unhealthy levels, are not receiving HIV care at participating clinics, or live outside the study sites are unlikely to receive direct benefit from this program.
Why it matters
Potential benefit: If successful, this could help people with HIV drink less, improve medication adherence and viral control, and make integrated alcohol care more available at HIV clinics.
How similar studies have performed: CETA and brief alcohol interventions have shown promise in prior mental health and alcohol programs, but their combined effect on HIV outcomes across Zambia and Alabama is still being tested.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Murray, Laura Kay — University of Alabama at Birmingham
- Study coordinator: Murray, Laura Kay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.